Evidence map›Paper›PMID 35693268›Full record

SynthesisComputational and mathematical methods in medicine2022

Efficacy of Platelet-Rich Plasma in the Treatment of Fractures: A Meta-Analysis.

Zhu Xu, Han Hu, Bin Wu, Chenglong Huang, Qin Liu, Bin Chen

RetractedOpen access · hybridAbstract readMeta-AnalysisRetracted Publication
In one paragraph

Synthesis in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Osteoimmunology of Fracture Healing.Current osteoporosis reports · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhu XuDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, China.
Han HuDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, China.
Bin WuDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, China.
Chenglong HuangDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, China.
Qin LiuDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, China.
Bin ChenDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, China.ORCID https://orcid.org/0000-0002-9279-6952
Jiaxing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although numerous studies have reported the effectiveness of platelet-rich plasma (PRP) in promoting and enhancing bone healing, many orthopedic physicians remain skeptical of platelet-rich plasma in the treatment of fractures. The objective of this meta-analysis was to assess the efficacy of PRP in the treatment of fractures. Methods: We search for research on PRP treatment of fractures in Pubmed, Embase, Medline, and Cochrane libraries. Two independent reviewers assessed included studies and met to develop a consensus on included studies. We also assessed the risk of bias using Review Manager 5.3 software. Results: The present meta-analysis included 10 randomized controlled trials (RCT) containing 652 patients. In the fixed-effect meta-analysis of 10 RCTs, 8 RCTs found that fracture patients benefited from PRP treatment. The use of PRP reduced the time of fracture healing in 4 RCTs. Three RCTs found that PRP adjuvant therapy enhanced bone mineral density in the fracture trace and reduced the time of bone regeneration in mandibular fractures patients (standardized mean difference (SMD) = -1.99, 95%confidence interval (CI) = -2.64--1.35). And 3 RCTs found that PRP adjuvant therapy decreased the risk of revision surgery in fracture patients (SMD = 1.83, 95%CI = 1.10-3.04). Conclusion: PRP adjuvant therapy is beneficial for the treatment of fracture patients, particularly those with mandibular fractures, and decreased the risk of revision surgery in fracture patients.

Indexed as

Mandibular FracturesPlatelet-Rich PlasmaCombined Modality TherapyHumansTreatment Outcome

Identifiers

PMID35693268
PMCPMC9184162
OpenAlexW4282037599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.